Cargando…
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection
Schistosomiasis is an important parasitic disease worldwide that affects more than 207 million people in 76 countries and causes approximately 250,000 deaths per year. The best long-term strategy to control schistosomiasis is through immunization combined with drug treatment. Due to the ability of D...
Autores principales: | Gonçalves de Assis, Natan Raimundo, Batistoni de Morais, Suellen, Figueiredo, Bárbara Castro Pimentel, Ricci, Natasha Delaqua, de Almeida, Leonardo Augusto, da Silva Pinheiro, Carina, Martins, Vicente de Paulo, Oliveira, Sergio Costa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420270/ https://www.ncbi.nlm.nih.gov/pubmed/25942636 http://dx.doi.org/10.1371/journal.pone.0125075 |
Ejemplares similares
-
Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine Development
por: Figueiredo, Barbara Castro-Pimentel, et al.
Publicado: (2015) -
Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice
por: Morais, Suellen B., et al.
Publicado: (2018) -
Sm29, but Not Sm22.6 Retains its Ability to Induce a Protective Immune Response in Mice Previously Exposed to a Schistosoma mansoni Infection
por: Alves, Clarice Carvalho, et al.
Publicado: (2015) -
Schistosoma mansoni SmKI-1 serine protease inhibitor binds to elastase and impairs neutrophil function and inflammation
por: Morais, Suellen B., et al.
Publicado: (2018) -
Sm10.3, a Member of the Micro-Exon Gene 4 (MEG-4) Family, Induces Erythrocyte Agglutination In Vitro and Partially Protects Vaccinated Mice against Schistosoma mansoni Infection
por: Martins, Vicente P., et al.
Publicado: (2014)